Behzad Foroutan

6.9k total citations
17 papers, 104 citations indexed

About

Behzad Foroutan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Behzad Foroutan has authored 17 papers receiving a total of 104 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Behzad Foroutan's work include Cancer-related Molecular Pathways (5 papers), DNA Repair Mechanisms (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Behzad Foroutan is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), DNA Repair Mechanisms (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Behzad Foroutan collaborates with scholars based in Iran and United Kingdom. Behzad Foroutan's co-authors include Diana Anderson, B. Costall, D. Jerwood, Razieh Bandari, Ali Karamoozian, Nahid Khalili, Amir Baghaei, Reza Mohtashami, H Fallah Huseini and Saeed Kianbakht and has published in prestigious journals such as Human and Ecological Risk Assessment An International Journal, Diabetes & Metabolic Syndrome Clinical Research & Reviews and Journal of Pharmacological and Toxicological Methods.

In The Last Decade

Behzad Foroutan

16 papers receiving 102 citations

Peers

Behzad Foroutan

SURGE

ONCOL

AMB

PPCH

Isabel Pinto Portugal

Marie‐Joe Dib United Kingdom

Céline Alloux France

Eléna Kiouris France

James R. Hilser United States

Mohamed Zein Egypt

Jorge Rico-Fontalvo Colombia

A I de Cos Spain

Chunjuan Zhai China

Angela Li United States

Isabel Pinto Portugal

Behzad Foroutan

55 ×2.0

6 ×0.3

SURGE

25 ×1.3

ONCOL

9 ×0.5

AMB

9 ×0.6

PPCH

Citations per year, relative to Behzad Foroutan Behzad Foroutan (= 1×) peers Isabel Pinto

Countries citing papers authored by Behzad Foroutan

Since Specialization

Citations

This map shows the geographic impact of Behzad Foroutan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behzad Foroutan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behzad Foroutan more than expected).

Fields of papers citing papers by Behzad Foroutan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behzad Foroutan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behzad Foroutan. The network helps show where Behzad Foroutan may publish in the future.

Co-authorship network of co-authors of Behzad Foroutan

This figure shows the co-authorship network connecting the top 25 collaborators of Behzad Foroutan. A scholar is included among the top collaborators of Behzad Foroutan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behzad Foroutan. Behzad Foroutan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Foroutan, Behzad. (2024). Osteoporosis Etiology, Epidemiology, Diagnosis, Diet, and Treatment: A Narrative Review. 8(2). 1–60. 1 indexed citations

Foroutan, Behzad. (2023). A Narrative Review of the <i>TP53</i> and Its Product the p53 Protein. 7(3). 1–71. 2 indexed citations

Foroutan, Behzad. (2023). A Narrative Review of the <i>TP53</i> and Its Product the p53 Protein. 7(3). 1–71.

Huseini, H Fallah, Saeed Kianbakht, Nahid Khalili, et al.. (2023). Antihyperglycemic efficacy and safety of AKROPOL, a Persian medicine poly-herbal extract mixture, in the treatment of type 2 diabetic patients: a randomized, double-blind and placebo-controlled clinical trial. 22(86). 1–13. 1 indexed citations

Foroutan, Behzad, et al.. (2021). Capabilities of bioinformatics tools for optimizing physicochemical features of proteins used in Nano biosensors: A short overview of the tools related to bioinformatics. Biochemistry and Biophysics Reports. 27. 101094–101094. 6 indexed citations

Foroutan, Behzad, et al.. (2021). Applying maggots to reconstruct a chronic diabetic foot ulcer “case report”. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 15(5). 102211–102211. 2 indexed citations

Karamoozian, Ali, et al.. (2021). Seasonal impact of air particulate matter on morbidity: Interaction effect assessment in a time-stratified case-crossover design. Human and Ecological Risk Assessment An International Journal. 27(9-10). 2328–2341. 6 indexed citations

Foroutan, Behzad, et al.. (2016). Small bowel obstruction attributable to phytobezoar. Oxford Medical Case Reports. 2016(12). omw092–omw092. 15 indexed citations

Foroutan, Behzad, et al.. (2015). Patients' views on observance of nursing ethics in Imam Hussein Hospital in Shahroud during 2015. 8(4). 81–90. 1 indexed citations

10.

Foroutan, Behzad. (2015). Personalized Medicine: A Review with Regard to Biomarkers. Journal of Bioequivalence & Bioavailability. 7(6). 11 indexed citations

11.

Bandari, Razieh, et al.. (2014). Six-Month Follow-Up Study of Ultrarapid Opiate Detoxification With Naltrexone. international journal high risk behaviors & addiction. 3(4). e20944–e20944. 4 indexed citations

12.

Foroutan, Behzad, et al.. (2014). Household storage of medicines and self-medication practices in south-east Islamic Republic of Iran. Eastern Mediterranean Health Journal. 20(9). 547–553. 31 indexed citations

13.

Foroutan, Behzad, et al.. (2014). Perioperative antibiotic prophylaxis in elective surgeries in Iran.. PubMed. 28. 66–66. 4 indexed citations

14.

Foroutan, Behzad, et al.. (2014). OVERCOMING CHEMORESISTANCE IN NON-HODGKIN LYMPHOMA PRELIMINARY STUDIES OF APOPTOSIS AND NECROSIS BY P-GLYCOPROTEIN REVERSAL AGENTS. Bradford Scholars (University of Bradford). 7(2). 382–388. 1 indexed citations

15.

Foroutan, Behzad, et al.. (2011). Molecular cytogenetic analysis of chemoresistant non-Hodgkin's lymphoma patients with p53 abnormalities using fluorescence in situ hybridisation and comparative genomic hybridisation.. PubMed. 14(5). 321–6. 3 indexed citations

16.

Foroutan, Behzad, et al.. (2006). An in vitro model to study chemoresistance in non-Hodgkin's lymphoma patients over-expressing mutant p53. Journal of Pharmacological and Toxicological Methods. 55(2). 151–158. 7 indexed citations

17.

Foroutan, Behzad, et al.. (2006). In vitro studies of DNA damage and its repair in cells from NHL patients with different p53 mutant protein status, resistant (p53+) and sensitive (p53−) to cancer chemotherapy. Journal of Pharmacological and Toxicological Methods. 55(1). 58–64. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact